Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 31, 2023 17:00 ET | Source: Chembio Diagnostics, Inc.; Biosynex

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

Complementary Technologies, Product Portfolios, and Market Opportunities Expected to Represent Significant Growth Drivers Consolidated Manufacturing, Sales, Marketing, Operations to Provide...
November 28, 2022 08:00 ET | Source: Chembio Diagnostics, Inc.

Chembio Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis System

HAUPPAUGE, N.Y., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the...
November 03, 2022 16:05 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports Third Quarter 2022 Financial Results

HAUPPAUGE, N.Y., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases,...
October 20, 2022 16:05 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics to Report Third Quarter 2022 Financial Results on November 3, 2022

HAUPPAUGE, N.Y., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
September 06, 2022 08:00 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay

HAUPPAUGE, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced it...
August 16, 2022 08:00 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Evaluates Monkeypox Rapid Point-of-Care Test Development

HAUPPAUGE, N.Y., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced it...
August 04, 2022 16:05 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports Second Quarter 2022 Financial Results

HAUPPAUGE, N.Y., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases,...
July 21, 2022 16:05 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics to Report Second Quarter 2022 Financial Results on August 4, 2022

HAUPPAUGE, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
June 15, 2022 08:00 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces Expansion of Direct-to-Consumer Commercial Channel

HAUPPAUGE, N.Y., June 15, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the...
May 24, 2022 16:15 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors

HAUPPAUGE, N.Y., May 24, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the...